Background Foodborne diseases are an important cause of global morbidity and mortality, particularly among children who often ...
Cover - Video on MSN
New 'Cow Tools' research transforms our understanding of bovine intelligence and proves famous cartoon wrong
Gary Larson's 1982 The Far Side cartoon Cow Tools has long delighted internet jokers - with its oblique anti-humour making it ...
Amazon S3 on MSN
Raw video: New 'Cow Tools' research transforms our understanding of bovine intelligence and proves famous cartoon wrong
Credit: Antonio J. Osuna Mascaró/Cover Images Gary Larson’s 1982 The Far Side cartoon Cow Tools has long delighted internet ...
Background IBD is characterised by recurrent flares, but evidence on whether modifiable dietary factors influence flare risk ...
Whole wheat bread generally offers more overall benefits over white bread when blood sugar is the primary consideration. White bread is more likely to trigger a sugar spike because it lacks the amount ...
The World Health Organisation will this year start to work with scientists and drug developers to gather more information ...
Large language models could transform digestive disorder management, but further RCTs are essential to validate their effectiveness and safety in healthcare.
The incidence and prevalence of heart failure with preserved ejection fraction (HFpEF) is increasing, along with the aging population and the ongoing rise in risk factors such as hypertension, ...
Objective To investigate the effectiveness of cryotherapy on pain intensity, range of motion (ROM), swelling and function in the postoperative care of musculoskeletal disorders. Design Systematic ...
Introduction Cardiac rehabilitation after type 1 myocardial infarction (type 1 MI) is an effective but underutilised method of preventing new cardiac events. This study aims to determine whether a ...
Aim To evaluate the effectiveness of atropine 0.01% in young premyopic and low-myopic children. Methods Children (5–9 years old) with premyopia (spherical equivalent refraction, SER+1.00 to −0.49D, n ...
The FDA is raising the bar for approval of CAR T-cell therapies in oncology. Under plans outlined by the FDA’s biologics chief Vinay Prasad, M.D., the agency will require developers of many CAR-Ts to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results